Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) RatMine GViewer (Genome Viewer) Overgo Probe Designer ACP Haplotyper Genome Scanner
Aging & Age-Related Disease Cancer Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

GENE - CHEMICAL INTERACTIONS REPORT

RGD ID: 2323
Species: Rattus norvegicus
RGD Object: Gene
Symbol: Cdkn2a
Name: cyclin-dependent kinase inhibitor 2A
Acc ID: CHEBI:2038
Term: 5-azacytidine
Definition: An N-glycosyl-1,3,5-triazine that is 4-amino-1,3,5-triazin-2(1H)-one substituted by a beta-D-ribofuranosyl residue via an N-glycosidic linkage. An antineoplastic agent, it is used in the treatment of myeloid leukaemia.
Chemical ID: MESH:D001374
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction is comprised of a complex set of reactions and/or regulatory events, possibly involving additional chemicals and/or gene products.
Object SymbolQualifierEvidenceWithReferenceSourceNotesOriginal Reference(s)
Cdkn2adecreases methylationEXP 6480464CTDAzacitidine results in decreased methylation of CDKN2A gene

PMID:21224363
Cdkn2aincreases expressionEXP 6480464CTDAzacitidine results in increased expression of CDKN2A mRNA

PMID:21224363
Cdkn2amultiple interactionsEXP 6480464CTD[Azacitidine co-treated with entinostat] results in decreased methylation of CDKN2A gene [Azacitidine co-treated with entinostat] results in increased expression of CDKN2A mRNA

PMID:21224363
Cdkn2aaffects methylationISORGD:7370396480464CTDAzacitidine affects the methylation of CDKN2A gene

PMID:18443271
Cdkn2adecreases methylationISORGD:7370396480464CTDAzacitidine results in decreased methylation of CDKN2A gene

PMID:17686055
Cdkn2amultiple interactionsISORGD:103226480464CTDAzacitidine inhibits the reaction [Particulate Matter results in increased methylation of CDKN2A promoter]

PMID:22355787
Cdkn2amultiple interactionsISORGD:7370396480464CTDHydroxyurea inhibits the reaction [Azacitidine results in decreased methylation of CDKN2A gene]

PMID:17686055
Go Back to source page   Continue to Ontology report